Gene: ANKRD16
Official Full Name: ankyrin repeat domain 16provided by HGNC
Gene Summary: Predicted to be involved in tRNA modification. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21656 | ANKRD16 Knockout cell line (HeLa) | Human | ANKRD16 | 1:3~1:6 | Negative | Online Inquiry |
KO21657 | ANKRD16 Knockout cell line (HCT 116) | Human | ANKRD16 | 1:2~1:4 | Negative | Online Inquiry |
KO21658 | ANKRD16 Knockout cell line (HEK293) | Human | ANKRD16 | 1:3~1:6 | Negative | Online Inquiry |
KO21659 | ANKRD16 Knockout cell line (A549) | Human | ANKRD16 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD16 Gene Knockout Cell Lines are genetically engineered cell lines in which the ANKRD16 gene has been specifically disrupted or “knocked out.” This process involves precise alterations in the DNA sequence, enabling researchers to explore the functional roles of ANKRD16 in cellular processes, signaling pathways, and disease mechanisms. ANKRD16 is known to play critical roles in cellular differentiation and immune responses, making its study pivotal in understanding various biological contexts.
The primary mechanism behind these knockout cell lines leverages CRISPR-Cas9 technology, which provides a highly efficient and targeted approach to gene editing. By inactivating the ANKRD16 gene, researchers can observe resultant phenotypic changes and dissect its contributions to specific cellular behaviors, such as proliferation, apoptosis, and response to external stimuli. This detailed examination is crucial for elucidating its potential involvement in pathology, especially in conditions like cancer, metabolic disorders, and autoimmune diseases.
The scientific significance of ANKRD16 Gene Knockout Cell Lines extends into both basic and applied research. In clinical settings, these cell lines aid in the identification of novel therapeutic targets and biomarkers, facilitating drug development and personalized medicine approaches. The ability to recreate disease models in vitro allows for more rapid and controlled experiments, enabling researchers to derive critical insights that can translate into clinical applications.
What sets our ANKRD16 Gene Knockout Cell Lines apart from other genetic models is the rigorous validation of gene disruption, coupled with a comprehensive characterization of their biological behavior. Our product is produced under stringent quality controls, ensuring reproducibility and reliability—key qualities that researchers and clinicians demand from their experimental systems. Moreover, they are readily available and compatible with a variety of assays, making them a versatile asset in any laboratory.
Investing in ANKRD16 Gene Knockout Cell Lines is a strategic choice for researchers and clinicians determined to unravel the complexities of gene function and its implications in disease. Our commitment to providing high-quality biological products is grounded in years of expertise in genetic engineering and molecular biology, ensuring that your research is supported by the best tools available on the market.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.